Latest news with #HyperthermicIntraperitoneal


Business Standard
28-07-2025
- Health
- Business Standard
Successful Completion of First CRS with HIPEC on a 60-year-old Woman with Advanced Peritoneal Carcinomatosis
PRNewswire Kolkata (West Bengal) [India], July 28: In a landmark achievement, a 60-year-old woman with advanced primary peritoneal carcinomatosis was successfully treated with Cytoreductive Surgery (CRS) combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at Manipal Hospital Dhakuria, under the expertise of Dr. Ashutosh Daga, Medical Oncologist, and Dr. Sagnik Ray, Surgical Oncologist. The 12-hour long procedure adds a milestone in cancer care treatment. The sexagenarian was initially taken to another hospital where she was misdiagnosed as a case of chronic liver failure with ascites. When she came to Manipal Hospital Dhakuria, she had trouble breathing and was admitted to the ICU. In the ICU, the fluid in her lungs was drained and chemotherapy was done. Initially, she needed chemotherapy every week but as soon as her condition improvised, she needed it once in three weeks. Subsequently, she was also shifted to the general ward. "We are proud to announce the successful completion of our first CRS with HIPEC at Manipal Hospital Dhakuria--an emerging center for comprehensive cancer care in Kolkata," saidDr. Ashutosh Daga. He went on to add, "Although we have previously performed a lot of CRS procedures and managed numerous advanced malignancies in collaboration with our medical oncologists, this was our first CRS case incorporating HIPEC that paves the way for complex procedures at the hospital for cancer patients." Cytoreductive Surgery (CRS) combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a highly specialized and evolving treatment modality used in the management of select gynecological, gastrointestinal, and occasionally thoracic malignancies. This complex procedure demands surgical precision and seamless coordination across multiple departments--including Anesthesiology, Critical Care, Physical Medicine, and Transfusion Medicine. Dr. Sagnik Ray said, "After 5 months of chemotherapy, she underwent optimal cytoreduction followed by intraoperative delivery of heated chemotherapy using a dedicated HIPEC machine, and she responded to the treatment in a positive manner. The patient had an excellent recovery and was discharged in stable condition on the 9th day of the surgery." About Manipal Hospitals As a pioneer in healthcare, Manipal Hospitals is among the top healthcare providers in India serving over 7 million patients annually. Its focus is to develop an affordable, high-quality healthcare framework through its multispecialty and tertiary care delivery spectrum and further extend it to out-of-hospital care. With the completion of the acquisition of Medica Synergie hospitals and AMRI Hospitals Limited (acquired in Sept 2023), the integrated network today has a pan-India footprint of 37 hospitals across 19 cities with 10,500+ beds, a talented pool of 5,600+ doctors and an employee strength of over 18,600. Manipal Hospitals provides comprehensive curative and preventive care for a multitude of patients from around the globe. Manipal Hospitals is NABH and AAHRPP accredited, and most of the hospitals in its network are NABL, ER, and Blood Bank accredited and recognized for Nursing Excellence. Manipal Hospitals has also been recognized as the most respected and patient-recommended hospital in India through various consumer surveys.


The Print
21-04-2025
- Health
- The Print
First-of-its-Kind Case in India: Malla Reddy Narayana Cancer Hospital Successfully Treats Primary Peritoneal Ewing's Sarcoma with Advanced HIPEC Surgery
Hyderabad (Karnataka) [India], April 21: Malla Reddy Narayana Cancer Hospital, Suraram, a premier cancer care centre in Telangana, held a press meet today at 11:30 AM within the hospital premises to announce a remarkable medical achievement: the successful treatment of a rare case of Primary Peritoneal Ewing's Sarcoma using an advanced procedure involving Cytoreductive Surgery (CRS) followed by Hyperthermic Intraperitoneal Chemotherapy (HIPEC). This rare and complex case involved 24-year-old Gautham Kumar, who had previously undergone two lines of chemotherapy at other institute, reached Malla Reddy Narayana Hospital for the Surgery. Diagnosed with Primary Peritoneal Ewing's Sarcoma , an exceptionally rare and aggressive malignancy that typically does not occur in the peritoneum. The diagnosis and subsequent treatment required a high level of expertise and precision, provided by a multidisciplinary oncology team led by Dr. Harish Dara, Senior Consultant – Surgical Oncology The surgical team undertook a challenging 16-hour procedure, which included complete tumor debulking followed by the direct infusion of heated chemotherapy into the abdominal cavity–a technique known as HIPEC. This innovative method is designed to eradicate any residual microscopic cancer cells, enhance chemotherapy absorption, and minimize damage to healthy tissues. HIPEC, now available at Malla Reddy Narayana Cancer Hospital, represents a significant advancement in the treatment of abdominal cancers such as ovarian, colorectal, gastric cancers, pseudomyxoma peritonei, mesothelioma, and certain rare sarcomas. Unlike conventional chemotherapy, HIPEC is delivered intra-operatively at elevated temperatures, significantly improving clinical outcomes. This successful case exemplifies the hospital's ability to manage rare and complex oncological conditions through advanced medical technology, surgical expertise, and a patient-centric approach. Quotes and Commentary Dr. Ch. Bhadra Reddy , Chairman, Malla Reddy Vishwavidyapeeth, stated: 'This extraordinary case reflects our ongoing mission to bring advanced and accessible cancer care to the region. We continue to invest in infrastructure, technology, and expertise that allow us to manage even the rarest and most challenging cases with confidence and care.' Dr. Ch. Preethi Reddy , Vice-Chairman, Malla Reddy Vishwavidyapeeth, stated: 'Treating Primary Peritoneal Ewing's Sarcoma with advanced HIPEC is extremely rare–both globally and in India–due to the rarity of the disease and the specialized nature of the treatment. It demands highly skilled surgeons, specialized infrastructure, and a dedicated multidisciplinary team. Malla Reddy Narayana Cancer Hospital stands among India's leading advanced cancer centres. We are proud to announce this success and I sincerely appreciate the commitment and excellence of our team of doctors.' Dr. Harish Dara , Senior Consultant, Surgical Oncology, commented: 'This case represents the best of surgical innovation and team collaboration. When combined with complete cytoreduction, HIPEC can offer patients a real chance at long-term survival in situations where traditional treatment options fall short.' Dr. G. Narendra Prakash , Senior Anaesthetist, shared: 'The success of this high-risk surgery required seamless coordination across multiple departments. Intraoperative stability was critical, and we ensured continuous monitoring and management throughout the extended duration of the procedure.' About Malla Reddy Narayana Cancer Hospital Located in Suraram, Hyderabad, Malla Reddy Narayana Cancer Hospital is a state-of-the-art oncology centre offering comprehensive cancer care. Through advanced diagnostics, expert multidisciplinary teams, and cutting-edge treatments such as HIPEC, the hospital remains at the forefront of personalized, precision-driven cancer therapy. For more information, please contact: * Malla Reddy Narayana Cancer Hospital, Suraram, Hyderabad * Website: * Toll-Free: 87903 87903 (ADVERTORIAL DISCLAIMER: The above press release has been provided by VMPL. ANI will not be responsible in any way for the content of the same) This story is auto-generated from a syndicated feed. ThePrint holds no responsibility for its content.